COMMUNIQUÉS West-GlobeNewswire

Akero Therapeutics to Present Data Reinforcing the Efficacy of Efruxifermin at the 75th Annual AASLD The Liver Meeting® 2024

21/10/2024 - 13:00

SOUTH SAN FRANCISCO, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked [...]

Skye Bioscience to Participate in Upcoming November Healthcare Investment Conferences

21/10/2024 - 13:00

SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced [...]

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

21/10/2024 - 13:00

Seer’s Proteograph™ Product Suite reveals new insights into Alzheimer’s pathways, drives population-scale plasma analysis, and captures immune dynamics in xenotransplantation—with additional breakthrough research from [...]

Breckenridge Brewery Unveils Annual Release of Funslinger Lager in Collaboration with Colorado Artist Mike Graves

21/10/2024 - 13:00

Opening Day Party Offers a Chance to Win Custom Never Summer Industries Artist Series Snowboards LITTLETON, Colo., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery , a subsidiary of Tilray Brands, Inc. (NASDAQ: [...]

PolyPid Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ in Prevention of Surgical Site Infections in Abdominal Colorectal Surgery

21/10/2024 - 13:00

SHIELD I Study is One of the Largest Phase 3 Trials in the Prevention of SSIs in Colorectal Resection Conducted in Over a Decade Pre-Specified and Post-Hoc Analyses Suggested that D-PLEX 100 May Benefit Patients with [...]

Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology

21/10/2024 - 13:00

Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology LONDON – Oct. 21, 2024 – Avacta Therapeutics (AIM: AVCT), a [...]

BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024

21/10/2024 - 12:45

MAINZ, Germany, October 21, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2024 on Monday, November 4, 2024. Additionally, the [...]

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers

21/10/2024 - 12:00

Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW171 in treatment of ovarian cancer, non-small cell lung cancer (NSCLC), and other mesothelin (MSLN) expressing cancers VANCOUVER, British [...]

Novo Nordisk A/S: Oral semaglutide demonstrates a 14% reduction in risk of major adverse cardiovascular events in adults with type 2 diabetes in the SOUL trial

21/10/2024 - 11:26

Bagsværd, Denmark, 21 October 2024 — Novo Nordisk today announced the headline results from the SOUL cardiovascular outcomes trial. The double-blinded, randomised trial compared oral semaglutide to placebo as an adjunct [...]

KFSHRC Launches Mobile Stroke Unit to Accelerate Patient Treatment

21/10/2024 - 11:12

A First in the Middle East and North Africa RIYADH, Saudi Arabia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has launched the first-of-its-kind Mobile Stroke [...]

Astex Pharmaceuticals Announce Key Data Presentations at the 36th EORTC-NCI-AACR Symposium

21/10/2024 - 10:00

CAMBRIDGE, United Kingdom, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, a pharmaceutical company based in Cambridge, UK, dedicated to the discovery and development of novel small molecule therapeutics for [...]

Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees

21/10/2024 - 10:00

Phase 3 DIAMOND-1 and DIAMOND-2 trials enrollment of OCS-01 in diabetic macular edema (DME) accelerated with great momentum DIAMOND program committees expanded with globally renowned retina experts If approved, OCS-01 [...]

Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update

21/10/2024 - 08:00

LONDON and RALEIGH, N.C., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for the third quarter ended September [...]

AAVantgarde appoints Ms. Lauren Kaskiel as Chief Business Officer

21/10/2024 - 08:00

MILAN, Oct. 21, 2024 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage, Italian-based international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector platforms for large [...]

ViaNautis Appoints Ray Jupp as Chief Scientific Officer

21/10/2024 - 08:00

ViaNautis Appoints Ray Jupp as Chief Scientific Officer Cambridge, UK 21 October – ViaNautis Bio (“ViaNautis” or the “Company”), a groundbreaking biotechnology company at the forefront of genetic therapies, today [...]

Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare

21/10/2024 - 07:30

Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare Sanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a significant [...]

Communiqué de presse : Sanofi et CD&R s’allient pour soutenir les ambitions d’Opella dans la santé grand public

21/10/2024 - 07:30

Sanofi et CD&R s’allient pour soutenir les ambitions d’Opella dans la santé grand public Sanofi et CD&R entrent en négociations exclusives pour le transfert d’une participation de contrôle de 50 % dans Opella ; [...]

ONWARD® Medical Announces Changes to Board of Directors, Including Addition of Medtech Leader Rob ten Hoedt as Incoming Chairman

21/10/2024 - 07:30

Ten Hoedt is a former Medtronic President and Executive Committee Member; also a former Chairman of MedTech Europe Commercial and digital health expert Rahma Samow will also join as Director Current Board Chairman Jan [...]

Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset

21/10/2024 - 06:00

The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-01 1 , a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases [...]